HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Preoperative Metformin May Improve Surgical Outcomes

By HospiMedica International staff writers
Posted on 29 Apr 2020
Print article
A new study suggests that preoperative metformin may be associated with decreased postoperative mortality and readmission in type 2 diabetes (T2D) patients.

Researchers at the University of Pittsburgh School of Medicine (Pitt; PA, USA) and the Veterans Affairs Pittsburgh Healthcare System (PA, USA) conducted a retrospective observational study involving 5,460 patients with T2D who underwent a major surgical procedure at one of 15 community and academic hospitals between 2010 and 2016. The main outcomes and measures were all-cause postoperative mortality, hospital readmission within 90 days of discharge, and preoperative inflammation, with or without preoperative metformin.

The results revealed that preoperative metformin was associated with a 3% 90-day mortality risk in the T2D patients who received preoperative metformin, compared to 5% in those who did not; patients in both groups had the same rate of 30-day mortality (2%). In addition, the 30-day readmission rate was also lower in the preoperative metformin group (11%), than in those without (13%). Preoperative inflammation was also reduced in the metformin group, compared to those without, as measured by mean neutrophil to leukocyte ratio. The study was published on April 8, 2020, in JAMA Surgery.

“This study found an association between metformin prescriptions provided to individuals with type 2 diabetes before a major surgical procedure and reduced risk-adjusted mortality and readmission after the operation,” concluded lead author Katherine Reitz, MD, of the PITT department of surgery, and colleagues, suggesting that “adults with comorbidity have less physiological reserve and an increased rate of postoperative mortality and readmission after the stress of a major surgical intervention.”

Metformin belongs to a class of drugs called biguanides, which inhibit the production of glucose in the liver. In addition to suppressing hepatic glucose production, metformin also increases insulin sensitivity, enhances peripheral glucose uptake, decreases insulin-induced suppression of fatty acid oxidation, and decreases absorption of glucose from the gastrointestinal tract.

Related Links:
University of Pittsburgh School of Medicine
Veterans Affairs Pittsburgh Healthcare System


Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Mechanical Baby Scale
seca 725

Print article

Channels

Critical Care

view channel
Image: The new risk assessment tool determines patient-specific risks of developing unfavorable outcomes with heart failure (Photo courtesy of 123RF)

Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients

Heart failure is a serious condition where the heart cannot pump sufficient blood to meet the body's needs, leading to symptoms like fatigue, weakness, and swelling in the legs and feet, and it can ultimately... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more